These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28400193)

  • 1. Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.
    Dietz AB; Dozois EJ; Fletcher JG; Butler GW; Radel D; Lightner AL; Dave M; Friton J; Nair A; Camilleri ET; Dudakovic A; van Wijnen AJ; Faubion WA
    Gastroenterology; 2017 Jul; 153(1):59-62.e2. PubMed ID: 28400193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Laureti S; Gionchetti P; Cappelli A; Vittori L; Contedini F; Rizzello F; Golfieri R; Campieri M; Poggioli G
    Inflamm Bowel Dis; 2020 Jan; 26(2):321-330. PubMed ID: 31220252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Results of a Phase I Trial Using an Adipose-Derived Mesenchymal Stem Cell-Coated Fistula Plug for the Treatment of Transsphincteric Cryptoglandular Fistulas.
    Dozois EJ; Lightner AL; Mathis KL; Chua HK; Kelley SR; Fletcher JG; Dietz AB; Friton JJ; Butler GW; Faubion WA
    Dis Colon Rectum; 2019 May; 62(5):615-622. PubMed ID: 30664554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
    Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
    Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas.
    Al-Maawali AK; Nguyen P; Phang PT
    Can J Gastroenterol Hepatol; 2016; 2016():1651570. PubMed ID: 28053967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas.
    Lightner AL; Dozois EJ; Dietz AB; Fletcher JG; Friton J; Butler G; Faubion WA
    Inflamm Bowel Dis; 2020 Apr; 26(5):670-677. PubMed ID: 31605115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S;
    Lancet; 2016 Sep; 388(10051):1281-90. PubMed ID: 27477896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
    Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
    Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
    Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T
    Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.
    Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V
    Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
    Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
    Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.
    Garcia-Olmo D; Herreros D; Pascual I; Pascual JA; Del-Valle E; Zorrilla J; De-La-Quintana P; Garcia-Arranz M; Pascual M
    Dis Colon Rectum; 2009 Jan; 52(1):79-86. PubMed ID: 19273960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    Barnhoorn MC; Wasser MNJM; Roelofs H; Maljaars PWJ; Molendijk I; Bonsing BA; Oosten LEM; Dijkstra G; van der Woude CJ; Roelen DL; Zwaginga JJ; Verspaget HW; Fibbe WE; Hommes DW; Peeters KCMJ; van der Meulen-de Jong AE
    J Crohns Colitis; 2020 Jan; 14(1):64-70. PubMed ID: 31197361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
    Lahat A; Assulin Y; Beer-Gabel M; Chowers Y
    J Crohns Colitis; 2012 Apr; 6(3):311-6. PubMed ID: 22405167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease.
    Castro-Poceiro J; Fernández-Clotet A; Panés J
    Immunotherapy; 2018 Oct; 10(14):1203-1217. PubMed ID: 30296868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
    Lightner AL; Reese J; Ream J; Nachand D; Jia X; Pineiro AO; Dadgar N; Steele S; Hull T
    J Crohns Colitis; 2023 Apr; 17(4):480-488. PubMed ID: 36322714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.